Inhibiting Extracellular Vesicle Release from Human Cardiosphere Derived Cells with Lentiviral Knockdown of nSMase2 Differentially Effects Proliferation and Apoptosis in Cardiomyocytes, Fibroblasts and Endothelial Cells In Vitro.
Numerous studies have shown a beneficial effect of cardiosphere-derived cell (CDC) therapy on regeneration of injured myocardium. Paracrine signaling by CDC secreted exosomes may contribute to improved cardiac function. However, it has not yet been demonstrated by a genetic approach that exosome rel...
Main Authors: | Jennifer K Lang, Rebeccah F Young, Hashmat Ashraf, John M Canty |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2016-01-01
|
Series: | PLoS ONE |
Online Access: | https://doi.org/10.1371/journal.pone.0165926 |
Similar Items
-
Dendrimer-Conjugated nSMase2 Inhibitor Reduces Tau Propagation in Mice
by: Carolyn Tallon, et al.
Published: (2022-09-01) -
Inhibition of nSMase2 Reduces the Transfer of Oligomeric α-Synuclein Irrespective of Hypoxia
by: Valerie Sackmann, et al.
Published: (2019-08-01) -
Neuronal deletion of nSMase2 reduces the production of Aβ and directly protects neurons
by: Sehmus Tohumeken, et al.
Published: (2023-02-01) -
Therapeutic Application of Extracellular Vesicles-Capsulated Adeno-Associated Virus Vector via <i>nSMase2/Smpd3</i>, Satellite, and Immune Cells in Duchenne Muscular Dystrophy
by: Yasunari Matsuzaka, et al.
Published: (2022-01-01) -
Microglial-Targeted nSMase2 Inhibitor Fails to Reduce Tau Propagation in PS19 Mice
by: Meixiang Huang, et al.
Published: (2023-09-01)